In the development of new drugs for cardiovascular diseases, once a drug candidate has been identified, the next step is to conduct preclinical safety, pharmacokinetic, pharmacodynamic, and pharmacologically relevant studies to observe the biological activity of the compound in specific cardiovascular diseases and to assess the safety of the compound to support the initiation of clinical trials.
Web: https://www.acetherapeutics.com/cardiovascular-diseases/preclinical-study-services-for-cardiovascular-drugs.html
